Spironolactone Tablet
Product Images NDC 50090-6909

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 50090-6909). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906909)

Label Image (Lbl500906909)
SPIRONOLACTONE 25 mg oral tablets label by A-S Medication Solutions, package containing 90 tablets. Label includes storage instructions to keep between 68 to 77 degrees Fahrenheit and to protect from light. The label also shows the product NDC 50090-6909.*
FDA Label Image

Figure (Spironolactone Fig1)

Figure (Spironolactone Fig1)
A Kaplan-Meier survival curve comparing the probability of an event over 42 months between two groups: Spironolactone (n=822) and Placebo (n=841). The y-axis represents probability from 0 to 1, and the x-axis shows time in months, with a significant difference (Log-rank p < 0.001) indicated between the groups.*
FDA Label Image

Fig2 (Spironolactone Fig2)

Fig2 (Spironolactone Fig2)
A forest plot depicting hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a clinical study comparing spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The x-axis ranges from 0.2 to 1.4, with arrows indicating whether spironolactone or placebo is favored.*
FDA Label Image

Str1 (Spironolactone Str1)

Str1 (Spironolactone Str1)
Chemical structure diagram of spironolactone, a synthetic steroidal compound. The image shows the molecular arrangement with labeled methyl groups (CH3) and functional groups, illustrating the compound's chemical framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.